drugset / Trial / NCT07101549

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

NCT07101549 ↗

Phase 1 Not yet recruiting 25 enrolled changjianhua
NaSingle-groupOpen-labelTreatment

Summary

A single-center, single-arm, dose-escalation exploratory clinical trial on the safety, efficacy, and pharmacokinetics of R-Star001 cell injection in patients with Nectin-4-positive advanced solid tumors.

Timeline

Start
2025-08-01
Primary completion
2027-08-01
Completion
2028-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject R-Star001 Cell therapy — —

Indications